CRSPBiotech
FollowFollowingUnfollowFree · no card
Get what investors say about CRSP next
1 investor call on CRSP in the last 90 days (1 bullish, 0 bearish). Follow CRSP free and new calls come to you in The Brief, our morning email, the day after we record them. This page shows them a week later.
or continue with Google ·
Who said what, and what CRSP did next
Every dot is a day someone on the record made a call. Hover one to see who. We are not scoring them — the point is that you can see it and judge for yourself.
Who’s talking about CRSP
| Date | Voice | Stance | Venue | Thesis |
|---|---|---|---|---|
| 2026-09-16 | Cathie WoodCEO & CIO, ARK Invest | Bullish | Livewire Markets | Crispr Therapeutics is already generating revenue from beta-thalassemia and sickle cell cures, and its… |
| 2026-03-23 | Cathie WoodCEO & CIO, ARK Invest | Bullish | Bloomberg Podcasts | CRISPR Therapeutics sits at the convergence of AI, sequencing, and gene editing — already generating revenue… |
| 2025-12-04 | Cathie WoodCEO & CIO, ARK Invest | Bullish | Money Maze Podcast | CRISPR Therapeutics is expanding from proven rare-disease cures (sickle cell, beta-thalassemia) into… |
| 2025-07-20 | Cathie WoodCEO & CIO, ARK Invest | Bullish | Cooper Academy | Convergence of AI, multi-omic sequencing technologies, and CRISPR gene editing is enabling one-time curative… |
| 2025-06-05 | Cathie WoodCEO & CIO, ARK Invest | Bullish | Chris Davis | CRISPR Therapeutics has commercialized the first gene-editing cure for sickle cell disease and beta… |
| 2024-10-17 | Cathie WoodCEO & CIO, ARK Invest | Bullish | RankiaPro | CRISPR Therapeutics has received FDA/UK/EU approvals for gene-editing cures for sickle cell and… |
Next report: 4 Nov 2026
Notable options days
Sessions in the last 120 where CRSP’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 5 of 120 sessions qualified.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-17 | ||||||
| 2026-08-25 | ||||||
| 2026-08-20 | ||||||
| 2026-08-19 | ||||||
| 2026-06-04 |
CRSP on the Wheel
CRSP did not pass our 1-month put test (V3); the Wheel shows its puts without calling one best.
The Wheel lists cash-secured puts on stocks after a 3% drop, with live quotes, the chance of assignment and each stock’s own history. Free to use; a free account lets you follow stocks, add your own and ask questions.
Decision support, not advice · questions put sellers ask us
Idea Scout
Following CRSP? Every Sunday we read the tape so you don't have to — who's recommending what, where they agree, and who just changed their mind. One free email a week.
Free · double opt-in · unsubscribe in one click